| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $3.4M | +33.9% |
| SG&A Expense | $2.3M | -0.0% |
| Operating Income | -$5.8M | -16.3% |
| Net Income | -$8.2M | +16.7% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -11.3% |
| Short-term Investments | $3.0M | — |
| Current Assets | $37.7M | -12.6% |
| Total Assets | $37.9M | -12.6% |
| Total Liabilities | $675K | -11.1% |
| Stockholders' Equity | $36.6M | -12.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | -97.9% |
| Capital Expenditures | $17K | -26.9% |
| Investing Cash Flow | -$2.9M | -200.2% |
| Financing Cash Flow | $2.2M | +176.0% |
| Free Cash Flow | -$3.7M | -96.4% |